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SCIENTIFIC OPINION 
Scientific Opinion on a review on the European Union Summary Reports 
on trends and sources zoonoses, zoonotic agents and food-borne outbreaks 
in 2009 and 2010 – specifically for the data on Salmonella, Campylobacter, 
verotoxigenic Escherichia coli, Listeria monocytogenes and foodborne 
outbreaks1 
EFSA Panel on Biological Hazards (BIOHAZ)
2, 3
 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
The European Union (EU) Summary Reports on trends and sources of zoonoses, zoonotic agents and food-borne 
outbreaks in 2009 and 2010 – specifically for the data on Salmonella, Campylobacter, verotoxigenic 
Escherichia coli, Listeria monocytogenes and foodborne outbreaks was reviewed. The main conclusions and 
recommendations are reported. Comparison between EU Member States (MSs) was found to be difficult due to 
the differences of the methods used, sampling schemes and reporting systems. Methods, sampling schemes and 
reporting systems among MSs should therefore be harmonised. When comparing MS-specific trends, the impact 
of sample sizes, weight of samples and methodologies should be considered, as these variables could otherwise 
lead to misinterpretation of the data. Incidence data alone do not provide a full picture of the public health 
burden of zoonotic diseases. Fatalities provide another important insight. Ultimately, summary measures of 
public health such as disability adjusted life years (DALYs) and cost-of-illness estimates should be presented. 
Travel information was found to be still incomplete in many MSs. For many pathogens this hampers source 
attribution. To better understand the public health problems related to food and animal sources in the EU, it is 
desirable to differentiate between travel within and outside the EU. This would also be useful to better evaluate 
the public health impact of EU-wide food safety measures. Whenever possible the data/results should be 
analysed using proper statistical tools. When data do not allow for this, the text should be kept to presenting the 
data without implying any patterns or trends.  
© European Food Safety Authority, 2012 
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SUMMARY 
The European Food Safety Authority (EFSA) asked the Panel on Biological Hazards (BIOHAZ) to 
deliver a Scientific Opinion on a review on the European Union (EU) Summary Reports on trends and 
sources of zoonoses, zoonotic agents and food-borne outbreaks in 2009 and 2010 – specifically for the 
data on Salmonella, Campylobacter, verotoxigenic Escherichia coli, Listeria monocytogenes and 
foodborne outbreaks. 
Comparison between EU Member States (MSs) is difficult due to the differences of the methods used, 
sampling schemes and reporting systems. Methods, sampling schemes and reporting systems among 
MSs should be harmonized.  
Data on human cases were reported via The European Surveillance System (TESSy) to ECDC by the 
27 MSs and three EEA/EFTA countries (Iceland, Lichtenstein and Norway). Switzerland reported 
human cases directly to EFSA. The completeness of reporting varied between both MSs and 
pathogens. 
The data reported to ECDC did not provide for an accurate picture of the epidemiological situation in 
the EU as they did not account for underreporting and under-ascertainment. The ratio between true 
cases and reported cases is known to vary widely between MSs and between pathogens, making 
comparisons extremely difficult. These limitations also affect the accuracy of risk assessment and 
attribution studies and furthermore may lead to inappropriate estimates of the cost-benefit ratio of 
interventions.  
Incidence data alone do not provide a full picture of the public health burden of zoonotic diseases. 
Fatalities provide another important insight. Ultimately, summary measures of public health such as 
disability adjusted life years (DALYs) and cost-of-illness estimates should be presented.  
Trends in reported cases are assumed to provide insight in the changes in disease incidence, and thus 
for the evaluation of control programs. Supporting evidence for the assumption that the sensitivity of 
surveillance systems does not change over the years has not been provided. Evaluation of the public 
health impact of food safety programmes is further hampered by a lack of risk factor information. 
Travel information is still incomplete in many MSs. For many pathogens this hampers source 
attribution. To better understand the public health problems related to food and animal sources in the 
EU, it is desirable to differentiate between travel within and outside the EU. This would also be useful 
to better evaluate the public health impact of EU-wide food safety measures. 
Whenever possible the data/results should be analysed using proper statistical tools. When data do not 
allow for this, the text should be kept to presenting the data without implying any patterns or trends. 
This also relates to use of words or phrases like “only” and “very low” contamination in e.g. RTE 
turkey and bovine meat, respectively. Such words imply an acceptance of the contamination level, 
which is outside the scope of the report. Phrases like “lower or higher than” are only considered 
appropriate to use when comparing trends from e.g. year to year, if supported by proper statistical 
analyses. 
When comparing MS-specific trends, the impact of sample sizes, weight of samples and 
methodologies should be considered, as these could otherwise lead to misinterpretation of the data. In 
addition data from MSs, where sample unit and sample size were unspecified could be presented in an 
annex. 
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BACKGROUND AS PROVIDED BY EFSA 
The Directive 2003/99/EC establishes the system on EU-wide data collection for zoonoses, zoonotic 
agents, antimicrobial resistance and food-borne outbreaks. The Directive assigns EFSA the tasks 
analysing the data and publishing in collaboration with ECDC annual EU Summary Reports on trends 
and sources zoonoses, zoonotic agents and food-borne outbreaks.  
Each year substantial quantities of data are received from the Member States and part of this data 
monitoring and reporting is harmonised by EU legislation or by EFSA specifications. The analyses of 
the data at supra-national EU level are challenging due to different epidemiological situations in the 
Member States and also because the data are not always directly comparable between the countries 
and years. 
The scientific panels of BIOHAZ and Animal Health and Welfare (AHAW) have been in the past 
consulted about the European Union Summary Reports from years 2004 and 2005, and two opinions 
from the panels have been issued on this review (EFSA Journal (2006) 403, 1-62 and EFSA Journal 
(2007) 600, 1-32). It would be appropriate to repeat this review of the EU Summary Reports for 2009 
and 2010 data collections (EFSA Journal (2011) 9(3):2090 and EFSA Journal (2012) 10(3):2597) in 
order to further improve the scientific quality of the reports, the data collection and the analyses 
carried out. 
 
TERMS OF REFERENCE AS PROVIDED BY EFSA 
The BIOHAZ panel is asked to: 
 Review the European Union Summary Reports on trends and sources zoonoses, zoonotic 
agents and food-borne outbreaks in 2009 and 2010. This review should in particular focus on 
data i.e. Salmonella, Campylobacter, verotoxigenic Escherichia coli, Listeria monocytogenes, 
food-borne outbreaks and other food-borne zoonoses, including current analyses of available 
data; 
 Evaluate the appropriateness of the data collected at EU level; 
 Consider what data are needed at EU level to provide an accurate picture of the 
epidemiological situation in the EU and the Member States; 
 Assess if the analyses methods used in the report are appropriate; 
 Consider if collection of sampled based data for the reports aim instead of aggregated data 
would improve the quality and analyses of data at EU level; 
 Consider if the data collection should be extended to additional zoonoses, or zoonotic or 
microbiological agents; 
 Propose any improvements to the data collection, the presentation of the data and their 
analyses and to the way harmonised monitoring is done. 
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ASSESSMENT 
1. Introduction 
EFSA is charged with coordinating the annual reporting of zoonoses, zoonotic agents, antimicrobial 
resistance and food-borne outbreaks in the European Union under Directive 2003/99/EC as well as 
analysing and summarising the data collected. 
Each year EFSA in close collaboration with the European Centre for Disease Prevention and Control 
(ECDC) analyses the data and publish a European Union (EU) Summary Report on trends and sources 
zoonoses, zoonotic agents and food-borne outbreaks based on the results. 
In order to improve the scientific quality of the EU Summary Reports it is appropriate to consult the 
relevant EFSA scientific panels regarding the best set of data to be collected and the analyses to be 
carried out. 
Consequently, EFSA invites the scientific panel on Biological Hazards (BIOHAZ) to review the EU 
Summary Reports on trends and sources zoonoses, zoonotic agents and food-borne outbreaks in 2009 
and 2010, specifically for the relevant diseases that are within the scope of the BIOHAZ Scientific 
panel, i.e. Salmonella, Campylobacter, verotoxigenic Escherichia coli, Listeria monocytogenes, food-
borne outbreaks and other food-borne zoonoses (EFSA, 2011a; 2012a).  
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2. Review of the 2009 and 2010 European Union (EU) Summary Reports  
2.1.1. Human data in general 
Data on human cases were reported via The European Surveillance System (TESSy) to ECDC by the 
27 EU Member States (MSs) and three EEA/EFTA countries (Iceland, Lichtenstein and Norway) for 
all diseases discussed in these documents. Switzerland reported human cases directly to EFSA. Graph 
SU1 presented comparative data on the reported incidence of zoonoses in the EU in a useful format. 
Campylobacter and Salmonella have remained by far the most frequently reported zoonoses in 
humans. More detailed information was provided in pathogen-specific chapters. Trend analyses were 
presented at EU-level when data were available. In addition, informative analyses on the breakdown of 
trends per MS have been provided. The completeness of reporting varied: in 2009 all 27 MSs plus 
three non-MSs reported data on Salmonella, one MS did not report data on Listeria, two MSs did not 
report data on Campylobacter, Trichinella, and Echinococcus, three MSs did not report data on VTEC 
and Yersinia. Fewer countries reported data on Toxoplasma. The results were adequately summarized 
in Chapter two. 
The data reported to ECDC did not provide for an accurate picture of the epidemiological situation in 
the EU as they did not account for underreporting and under-ascertainment. The ratio between true 
cases and reported cases is known to vary widely between MSs and between pathogens, making 
comparisons extremely difficult. These limitations also affect the accuracy of risk assessment and 
attribution studies and furthermore may lead to inappropriate estimates of the cost-benefit ratio of 
interventions. Tam et al. (2012), in the UK IID-2 study, have described a cohort-based approach to 
estimate multipliers for a range of intestinal pathogens. Havelaar et al. (2012a) have described a 
modelling approach based on comparative risks of Swedish travellers to different EU MSs to estimate 
multipliers for salmonellosis and campylobacteriosis. Their results have been used in several EFSA 
Opinions (EFSA, 2008a; 2008b; 2011b; 2011c). ECDC is addressing this problem in the Burden of 
Communicable Diseases in Europe (BCoDE) project (ECDC, 2012).  
Trends in reported cases are assumed to provide insight in the changes in disease incidence, and thus 
for the evaluation of control programs. Supporting evidence for the assumption that the sensitivity of 
surveillance systems does not change over the years has not been provided. The reports both 
mentioned problems related to differences in methodology applied in different MSs, related to changes 
in the number of MSs reporting, etc. Further information on health care-seeking behaviour of patients 
in different MSs and further information on the operation of the health care systems (sample 
submission, analysis for specific pathogens, sensitivity and specificity of laboratory methods, 
effectiveness of reporting systems etc.) should be available to allow more meaningful comparisons on 
reported data. Other possible explanations such as changes in food preparations and consumption 
patterns might also be responsible for at least a part of the observed changes in observed disease 
incidence, but are not specifically addressed. More data are needed on details of surveillance systems 
to better interpret and possibly standardize the reported data. Sero-epidemiology is an alternative, 
surveillance-system independent tool to evaluate the exposure of populations to intestinal pathogens, 
and thus the impact of food safety interventions. The applicability of sero-epidemiology is currently 
being explored by ECDC. 
Evaluation of the public health impact of food safety programmes is further hampered by a lack of risk 
factor information which makes it very difficult to interpret observed trends. 
Incidence data alone do not provide a full picture of the public health burden of zoonotic diseases. 
Fatalities provide another important insight and from data presented in the report, Listeria is the cause 
of most deaths related to reported cases.  
Ultimately, summary measures of public health such as disability adjusted life years (DALYs) and 
cost-of-illness estimates should be presented (Gkogka et al., 2011; Havelaar et al., 2012b). This is the 
aim of the ECDC BCoDE project (Kretzschmar et al., 2012). Where available, specific data on health 
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care usage (GP visits, hospitalisation, severe sequelae such as Guillain-Barré syndrome and 
heamolytic-uraemic syndrome) - an indication of severity - could be included in the EU Summary 
Reports. 
Travel information is still incomplete in many MSs and for many pathogens this hampers source 
attribution. To better understand the public health problems related to food and animal sources in the 
EU, it is desirable to differentiate between travel within and outside the EU. This would also be useful 
to better evaluate the public health impact of EU wide food safety measures. 
2.2. Salmonella  
The Salmonella data were for the most part well-presented and relevant in both reports. It may be 
worth considering omitting the introductory section, which seems to reproduce text book material. If 
retained in future EU Summary Reports, the introduction section would benefit from a more critical 
appraisal of known facts about the organism and the methods of characterisation. For example, in both 
reports it is stated that „more than 2,500 serovars of zoonotic Salmonella exist.  This is not strictly 
correct. Although >2500 serovars have been identified, less than 1000 (and probably less than 500) 
have been isolated from animals and can therefore be regarded as truly „zoonotic‟. Indeed, many of the 
more exotic serovars, which have for the most part been initially identified in developing countries, 
have only been observed in humans. Furthermore it should be realised that the incubation period for 
human salmonellosis can extend for up to 72 hours or even more, depending on the ingested dose and 
other factors such as the vehicle of infection and the immune status of the host. Additionally, in the 
reports there was inconsistency in the use of „serovar‟ and „serotype‟ throughout the documents. Both 
terms have been used – „serovar‟ is now considered the most appropriate term. The paragraph 
describing the most common sources of S. Enteritidis and S. Typhimurium should not be mentioned in 
the introduction as a matter of fact. This may be the current epidemiological situation, but this may 
change over time. The sources of different serovars should be discussed in a section devoted for taking 
stock of the epidemiological situation and observed trends – a concluding section on Salmonella, 
where all major findings are discussed.  
2.2.1. Salmonellosis in humans  
Salmonellosis is the second most frequently reported zoonosis in EU and the reported incidence 
continues to decrease. The reported incidence has been presented in a Table and trends over five years 
were visualized for the EU and for each reporting MS in graphs and analysed statistically for trend, 
which is very informative. Major differences in reporting MSs, that may affect overall trend, have 
been noted. The data collected were case-based, except for two MSs reporting aggregated data. The 
presentation of data is considered appropriate. The countries providing no case-based data could be 
excluded from the Table and be presented as a footnote. Strong deviations in reported cases per 
100.000 among MSs were neither noted nor explained or discussed, i.e. several MSs reporting less 
than 10 cases per 100,000. Such countries could be excluded from calculating the total EU incidence. 
Information on domestic/imported origin of cases has been presented in tabular form. As there are still 
many MSs with no or incomplete information, presenting an EU average is not very informative. 
Furthermore, there is strong geographical variation in the domestic or imported origin of cases, which 
is not reflected in an EU average. Collecting travel information on reported cases should be a priority 
in all MSs (see also 2.1.1). 
The data on seasonality were presented in a single graph combined with serovar distribution in 2009, 
and combined with age distribution in 2010. It is not clear why these differences in presentation have 
been chosen. Whether seasonality differs between MSs or geographical regions has not been 
evaluated. Age distribution of cases could be discussed more extensively. There was detailed 
information on (evolution of) serovar distribution and time trends, which assists in understanding 
overall trends in more detail. 
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2.2.2. Data on Salmonella in foods  
Data on Salmonella in food have been presented in Tables by animal species of origin i.e. broilers, 
turkeys, table eggs, pig meat etc. For each animal species, the results were presented by reporting MSs 
in a single Table and divided into results obtained at slaughter, processing/cutting plant and retail. A 
total percentage of Salmonella-positive samples for reporting MSs has been given at the bottom of 
each Table. Such an overall Salmonella-positive sample percentage is difficult to interpret as it 
includes results from a mixture of surveys with different sampling designs, sampling sizes, sampling 
approaches, etc. Also, there is a risk that readers are interpreting this as the “EU average”, which is 
even less meaningful, since not all MSs reported data. One purpose of a total average should be to 
analyse any significant trends occurring from e.g. one year to the next, although without harmonised 
monitoring schemes this is not possible.   
The results have been mostly described by “eyeballing”. Some general remarks have been made such 
as “data from the MSs reporting investigations at different sampling stages, showed that samples 
tested at slaughter were found to be more contaminated than samples tested later in the food chain”. 
Such an observation may leave a false impression that the products at retail are less contaminated, 
while the explanation may rather be due to the variations in sampling strategies (including what the 
individual sample is actually representing: carcass, pork chop, minced meat etc.) as described above. 
Also, the observation is not true for all MSs. 
Overall, whenever possible the data/results should be analysed using proper statistical tools. When this 
is not possible, the text should be kept to presenting the data without implying any patterns or trends. 
This also relates to use of words or phrases like “only” (e.g. only 0.6% positive samples of egg 
products) and “very low” (e.g. very low (0.8% and 0.4%) contamination in RTE turkey and bovine 
meat, respectively), which imply an acceptance of the contamination level, which is outside the scope 
of the report. Phrases like “lower or higher than” is considered appropriate to use when comparing 
trends from e.g. year to year, if supported by proper statistical analyses. 
There was a specific paragraph dealing with non-RTE foods, but what is meant by this has not been 
adequately explained. In principle it should include all products sold at retail that are not RTE foods, 
but then the results from the Tables were not in accordance with what is described in the text. The 
relevance of including a paragraph describing the results of sampling non-RTE food should be 
considered, as it is assumed that these are already in the Tables in some form. If it is decided to retain 
this paragraph, a better explanation should be provided. 
The Tables describing the RTE foods are useful. The use of a “total proportion of Salmonella-positive 
samples” is considered to be more meaningful to apply here than for the other Tables, although 
interpretation should be done with caution due to the factors described above. 
When comparing MS-specific trends, the impact of sample sizes should be considered. For instance in 
Figure SA6, the occurrence of S. Enteritidis in table eggs from six MS over three years has been 
presented and discussed in the text. From the figure some countries (e.g. Greece), appear not to have 
had S. Enteritidis in table eggs in the three-year period, whereas in Germany a declining trend was 
observed. When looking at the sample sizes in Table SA11 (EFSA, 2011a), it can be seen that many 
more samples were collected in Germany. It is very likely that if a similar number of samples had been 
collected in Greece, the apparent prevalence would have been different from zero. This possibility is 
supported by the finding of S. Enteritidis in laying hen flocks in Greece (Table SA22). The 
consideration of sample sizes is particularly important when dealing with food sources, where the 
expected number of Salmonella-positive samples is low, such as is the case with table eggs. 
In the food Tables, sample weight (or sample area in cm
2
) has been indicated, but the impact that the 
different sample weights/sizes may have on the results was not discussed. An example of this is in the 
description of bovine RTE foods, where Poland was highlighted as having the highest proportion of 
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positive samples. In contrast to all other MSs in this Table, Poland took 200 g samples, which would 
be expected to result in higher positivity.  
In Table SA16, it is not clear why there is a category called “Vegetables” and another named “Fruit 
and vegetables”, and if investigations of vegetables were reported in both.  
2.2.3. Data on Salmonella in animals  
The section began with a short description of the species for which harmonised monitoring, national 
control programmes and targets are implemented. A new Table inserted in this section, listing for each 
animal species (or production type) which serovars are targeted, what the targets are and how many 
MSs that have met the targets, is recommended. Such information has, of course, been presented under 
the respective animal species, but an overview Table is considered useful.  Due to the harmonised 
monitoring and, if the production type exists in the MSs, all MSs report data, the use of EU total 
average is considered appropriate and the overall presentation of the results was clear and useful. The 
description of the target set for laying hens (EFSA, 2011a, p. 65) fails to describe the serovars that 
have been targeted (i.e. S. Enteritidis and S. Typhimurium). The data collected at the flock level were 
also clearly described, but in several places these were referred to at the sample level - e.g. “The MSs 
reported between 0 % and 10.9 % samples positive with S. Enteritidis and/or S. Typhimurium” (EFSA, 
2011a; Table SA22, p. 67). This should be „flocks‟ as more than one sample is collected per flock and 
a single Salmonella-positive sample results in a flock being declared Salmonella-positive.    
No harmonised monitoring currently exists for Salmonella in pigs and cattle, as well as other farm 
species. The data reported were therefore sparse and the possibility to make for instance trend analyses 
is restricted to a very few MSs which report annual results from a national control programmes. The 
text describing these results was therefore kept short without many interpretations, which is considered 
appropriate. 
2.2.4. Data on Salmonella in feeds 
This section has briefly described the overall Salmonella findings in feed materials and compound 
feeding stuff. The focus has been on compound feeding stuffs presumably because this is the feed 
ready to be fed to the animals. A large proportion of the feed materials is also fed directly to the 
animals without further treatment. This includes, for instance, oil-based products such as soy and rape, 
which are recognised sources of Salmonella. A large proportion of these feed materials are imported 
from outside EU. Some are processed further at feed plants, but some are distributed directly to e.g. 
pig and cattle farms. More information (if available) on the serovar distribution in feed materials 
(particularly the oil-based products) could be useful, and may shed light on the origin of some of the 
Salmonella findings in animals that tends to occur in clusters in a group of MSs and/or over a shorter 
time period.    
2.2.5. Evaluation of the impact of Salmonella control programmes in poultry 
Overall, the included figures and analyses are considered appropriate. Further in-depth data analysis 
could follow the recommendation in EFSA (2011b) “The establishment of active surveillance of 
human salmonellosis in all Member States is recommended, including harmonised typing of human 
Salmonella isolates and efforts to quantify the level of under-ascertainment and underreporting”. In the 
very last paragraph in the 2010 report possible explanations to the reduction in both human cases and 
Salmonella-positive Gallus gallus flocks has been provided. Here voluntary and compulsory 
vaccination have been underlined as factors possibly contributing to the reduction, and were the only 
factors specifically mentioned (except for “other hygiene-based control measures”). It may have been 
more appropriate to have also mentioned the general the control of Salmonella in breeding flocks. For 
an assessment of the usefulness of vaccination for control of Salmonella in poultry reference should be 
made to: Opinion of the Scientific Panel on Biological Hazards on a request from the Commission 
related to the use of vaccines for the control of Salmonella in poultry (EFSA, 2004).  
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The 2010 report also referred to the EFSA Opinion on laying hens, stating that 65% of all human 
salmonellosis cases can be attributed to the laying hen reservoir (EFSA, 2010a). This is not the correct 
reference. The reference should have been EFSA (2011b). Also, the inclusion of published confidence 
limits when referring to such model results would have been worthwhile. 
Finally, this section may have been better placed following the description of the results from the 
harmonised monitoring in poultry. 
2.2.6. Salmonella serovars 
The report would benefit from including MS-specific data on the serovar distribution in humans. This 
would aid the comparison of the serovar distribution through the food chain and be valuable for 
assessing the trends and dynamic of human salmonellosis as well as evaluating the effect of control 
efforts in the food chain. As recommended in EFSA (2011b) “Close monitoring of the serovar 
distributions in humans and broilers should be strengthened to identify the emergence of serovars of 
public health significance”, and emerging serovars could be identified more explicitly in future EU 
Summary Reports. 
In the 2010 report, a decrease of 2,088 cases of S. Typhimurium was described. The 2009 figures 
included isolations of the monophasic S. Typhimurium strains but this was not the case for the 2010 
data report, where these strains were reported separately (EFSA, 2011a; 2012a). This means that the 
actual decrease from 2009 to 2010 was considerably less than the above mentioned figures showed.   
It should also be kept in mind that when isolates of major serovars such as S. Enteritidis and S. 
Typhimurium are decreasing in numbers, the relative importance of other serovars may increase 
without necessarily representing an absolute increase. When discussing the trend of specific serovars 
in human, the absolute numbers should therefore also be considered. 
In relation to the phage typing data both reports have not fully considered the genetic „make-up‟ of 
certain phage types and the implications on the figures presented. For example, in the 2009 data report 
(EFSA, 2011a), in relation to serovars in humans (p. 92, para 6), for S. Typhimurium it should be 
realised that DT193 is a composite phage type which is comprised of at several „clades‟ or „clones‟, 
which are for the most part unrelated and can only be distinguished by molecular subtyping. 
Additionally „RDNC‟ and „NT „(Table SA33) are not distinct phage types. „RDNC‟ means‟ reacts but 
does not conform, and is a conglomeration of strains with different phage reactions which have not 
been assigned to a recognised phage type; „NT‟ means‟ not typeable‟ and the same considerations as 
those to  „RDNC‟ apply – i.e., both „RDNC‟ and „NT‟ can represent several unrelated strains. These 
two types should therefore be included at the bottom of Table SA33, possibly just before „Other‟, or 
even combined with „Other‟. It should also be noted that „U302‟ (p. 93, para 1, line 2) is not a 
definitive phage type. The considerations on „RDNC‟ and „NC‟ also apply to the S. Enteritidis phage 
typing data (Table SA31, p. 87-88). As explained above, „RDNC‟ is not a single phage type and 
should therefore should be included at the bottom of columns in Table SA33 (p. 94).  
The same criticism can be extended to human TESSy data the 2010 report, where in Table SA31 (p. 
91) the TESSy returns included „RDNC‟ as a phage type for both S. Enteritidis and S. Typhimurium 
(ranked as numbers 5 and 3, respectively in Table SA31), and NT as a phage type for S. Typhimurium 
(ranked as number 8).   
For human salmonellosis, the 2009 report would have benefited from mentioning of the appearance of 
S. Typhimurium DT191 in 2009. It is clear from Table SA33 (p. 94) that this type emerged in 
significant numbers in humans in 2009 but was not seen in isolates from food animals. The number of 
infections identified (237) is quite substantial. A short note about the reservoir of this phage type – 
corn snakes fed on imported frozen infant mice imported into the EU from the USA - (Harker et al, 
2011), would have been informative,  particularly as the type does not appear in the ‟top ten‟ in the 
2010 data report (EFSA, 2012a), following the implementation of international control measures.  
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For the non-human sources, available serovar data were presented in the order: meat, primary 
production and feed. The resulting serovar distributions were used to make comparisons of the serovar 
distributions between the different links in the food chain and to humans. These comparisons were 
also discussed further in the last section “Overview of Salmonella from farm-to-fork”.  
Apparently, two different data sets were available for the serovar distributions; the serovar Tables in 
which only the serovar distribution have been reported and the prevalence Tables, which also included 
the number of units tested. For the outside reader, this distinction is not clear and the limitations of 
both data sets for providing representative serovar distribution should be better described.  
The serovar distribution for Gallus gallus (presumably from the serovar Tables) has not distinguished 
between the broiler and laying hen reservoir, making the comparison of the serovar distribution 
between the different links in the food chain and to humans difficult. Because of this limitation, the 
overall comparisons have put more emphasis on the serovar distribution in broiler meat. Since less 
than half of the MSs reported data from investigations of broiler meat in 2009 and 2010, this may lead 
to misinterpretation of the data. For instance in the 2010 report, S. Kentucky was mentioned as 
associated with broilers (p. 108). From the Tables the dominance of S. Kentucky in broiler meat was 
driven only by a single country and relied on relatively few samples. Indeed, from a more detailed 
scrutiny of the data reported at the flock level through the harmonised monitoring, the prevalence of S. 
Kentucky can be seen to be higher in turkeys than in broilers (EFSA, 2012b).  
Serovar distributions to the extent possible were based on data from harmonised monitoring, where 
also the prevalence (proportion positive) was taken into account. Comparison of serovar distributions 
across the food production chain is therefore recommended.  
The 2010 EU Summary Report (EFSA, 2012a) provided a helpful commentary on the newly-emerging 
monophasic S. Typhimurium-like strains (p. 100). This is particularly relevant since, as stated, the 
current tetra-resistant DT193/DT120 epidemic strain cluster has spread beyond its initial porcine 
source and in 2010 has been identified in other food-animal reservoirs, including poultry. The 
information in this commentary is also useful, since the mechanism of reporting of monophasic S. 
Typhimurium differs between countries, with some countries reporting such strains by phage type 
(DT120/DT193), and not as „monophasic‟, or by antigenic structure. Thus the information presented in 
Table SA31 (p91) included isolates of both DT193 and DT120 in the S. Typhimurium phage types 
listed for both years. As it is highly probable that a significant number of isolates of these phage types 
were monophasic, the proportion of such monophasic isolates is likely to be considerably in excess of 
those reported in 2010 as „S. Typhimurium monophasic‟ (EFSA, 2012a; Table SA30, p90).  
As recommended in EFSA (2010b) “The antimicrobial resistance pattern should be determined and 
reported in a harmonised way for human, animal and food isolates, according to European guidelines”. 
According to EFSA (2008b) “Data gathering for purposes of attribution should be question driven and 
by representative sampling. Baseline studies, as carried out under the Zoonoses Regulations, are an 
important development. It is recommended that all Salmonella isolates from cases of human illness 
and a representative set of isolates from all main animal species entering the food chain is serotyped in 
all MSs and that at least the common serotypes such as S. Enteritidis and S. Typhimurium are 
subtyped using harmonised and appropriate methods.” For Salmonella, serotyping is universal for all 
countries, whilst many countries in the EU also use the same schemes for the phage typing of S. 
Enteritidis, and most for S. Typhimurium. Harmonised molecular typing based on pulsed field gel 
electrophoresis (PFGE) is now widely in use in many countries world-wide but less useful for 
attribution purposes. For attribution purposes sequence-based methods, such as Variable Number of 
Tandem Repeats (VNTR) analysis are being harmonised for S. Typhimurium and S. Enteritidis and the 
results should be more amenable to transfer between countries. If possible, reporting of molecular 
subtypes of S .Enteritidis and S. Typhimurium based on VNTR analysis is recommended for future EU 
Summary Reports. 
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2.2.7. Overview of Salmonella from farm-to-fork 
This section has provided a comprehensive overview of the presented Salmonella data and also 
included references and discussions to additional data or reports considered important for the 
interpretation of the data. No specific comments or recommendations are made for this section, but 
points mentioned previously should also be considered and included when developing this section for 
future EU Summary Reports. 
2.2.8. Conclusion and discussion 
The Salmonella data were for the most part well-presented and relevant in both the 2009 and 2010 EU 
Summary Reports (EFSA, 2011a; 2012a). Consideration should be given to omitting the introductory 
section, which seems to reproduce text book material. If retained in future EU Summary Reports, the 
introduction section would benefit from a more critical appraisal of known facts about the organism 
and the methods of characterisation. 
The sources and/or reservoirs of different Salmonella serovars should be discussed in a section 
devoted to the epidemiological situation and observed trends. This could be discussed in a concluding 
section on Salmonella, where all major findings are discussed. 
A total percentage of Salmonella-positive samples in food for reporting MSs was very difficult to 
interpret as it included results from a mixture of surveys with different sampling designs, sampling 
sizes, sampling approaches, etc., and there is a risk that it will be misinterpreted as the “EU average”. 
One purpose of a total average is to analyse trends, but without harmonised monitoring schemes this is 
not possible.  
Description of trends should be supported by proper statistical tools. When data do not allow for this, 
the text should be kept to present the data without implying any patterns or trends. When comparing 
MS-specific trends, the impact of sample sizes and weight of samples should be considered, as it could 
otherwise lead to misinterpretation of the data. 
For the Salmonella data from animals, inclusion of a new Table listing for each animal species (or 
production type), which serovars are targeted, what the targets are and how many MSs that have met 
the targets is recommended. 
The appropriate epidemiological unit (e.g. sample, flock or herd) should be used when presenting the 
data in the text.  
More information (if available) on the serovar distribution in feed materials (particularly the oil-based 
products) would be useful, as this may shed light on the origin of some of the Salmonella findings in 
animals that tends to occur in clusters in a group of MSs and/or over a shorter time period. 
The EU Summary Reports would benefit from including MS-specific data on the serovar distribution 
in humans. This would aid the comparison of the serovar distribution throughout the food chain and be 
valuable for assessing the trends and dynamics of human salmonellosis as well as evaluating the effect 
of control efforts in the food chain. 
The presentation of Salmonella subtypes (e.g. phage types) should be considered carefully, taking into 
account the actual meaning of the notations given to the subtypes. Particularly, the strains given the 
notation “RDNC” or “NT” should be recognised as strains for which it was not possible to assign a 
distinct phage type. Such strains should be reported in the bottom of the Tables. 
The serovar distributions should, to the extent possible, be based on data from harmonised monitoring, 
where also the prevalence (proportion positive) is taken into account when comparing serovar 
distributions across the food production chain.  
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If possible, reporting of molecular subtypes of S .Enteritidis and S. Typhimurium based on VNTR 
analysis is recommended for future EU Summary Reports. 
2.3. Campylobacter  
2.3.1. Campylobacteriosis in humans/reported cases  
Campylobacteriosis is the most frequently reported zoonosis in EU and the reported incidence 
continues to increase. The reported incidence has been presented in a Table and trends over five years 
were visualized for the EU and for each reporting MS in graphs and analysed statistically for trend, 
which is very informative. Major differences in reporting systems, that may affect trend, have been 
noted. The data collected were case-based, except for one MS reporting aggregated data; one MS did 
not report any cases in 2009 and only one case in 2010. Two MSs did not report campylobacteriosis in 
both years. The presentation of data was appropriate but the countries providing no case-based data 
could be excluded from the Table and be presented as a footnote. Strong deviations of reported cases 
per 100.000 were neither noted nor explained, i.e. several MSs reporting less than ten or even less than 
one case per 100,000. Such countries could be excluded from calculating the total EU incidence. 
Table CA3 on domestic/imported origin of cases in the 2009 report was discontinued in the 2010 
report. In the 2010 report, available travel information was provided in text form. This is appropriate 
as in many MSs, travel information is still incomplete or fully absent. Collecting such information 
should be a priority in all MSs (see also 2.1.1). 
The data on age-specific distribution from a subset of MSs has been presented as a graph in an 
appropriate way. The seasonality has also been appropriately shown as a graph, indicating the number 
of confirmed cases per month for the whole EU (with few exceptions). The presentation of cumulative 
data for the whole EU may be less informative than an analysis by region because the seasonality 
differs between MSs (geographical regions). It could be at least amended by adding individual graphs 
for each MS or for representative regions. 
Species distribution was given in text form. There was a lack of speciation for a large proportion of 
cases (51% in 2009 and 51.8% in 2010). Data on speciation per MS would be useful in addition to the 
aggregated results. No subtype data have been reported although according to EFSA (2010c) “To 
provide a better understanding of the molecular epidemiology of campylobacteriosis and a better basis 
for source attribution in the EU, it is recommended that a representative collection of isolates from 
humans and putative reservoirs (in particular food-producing animals but also other domestic and wild 
animals) is obtained and subjected to genotyping in all MSs”. Currently the most appropriate method 
of genotyping appears to be MLST. Storage of the isolates and their DNA is recommended, so that in 
the future, potentially improved subtyping methods could be applied. This should be regarded as a 
matter of urgency as a baseline is needed before EU-wide controls are considered in the broiler meat 
production chain. 
2.3.2. Data of Campylobacter in animals and food 
2.3.2.1. Data on Campylobacter in animals 
Data from poultry, pigs, cattle and other farm animals as well as pets were reported. The Tables on 
prevalence in broilers and other poultry and in pigs comprised data on animal-based sampling and 
flock/herd-based sampling together. 
The EU-wide baseline survey for poultry has been presented separately from the above mentioned data 
in the 2009 data report (EFSA, 2011a) and comprised prevalence data of Campylobacter-colonised 
broiler batches.  
For cattle a great variety of descriptions has been given, representing dairy cows, meat production 
animals, calves, other age groups or unspecified. Thus a comparison is very difficult. In addition also 
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for cattle data sets have been divided in animal-based and herd-based data. Only for animal-based data 
were there enough samples were provided from MSs. Therefore, a comparison between MSs in 
relation to herd-based data was not possible. 
No data from other farm animals that allow reporting of prevalence have been provided.  In addition 
data were mainly derived from clinical investigations from sheep and goats.  
For cats and dogs data from several MSs were available with appropriate sample sizes but the origin of 
the samples was not specified. Furthermore clinical and diagnostic samples have been included, which 
makes interpretation difficult.  
The Campylobacter species distribution for broilers, cattle and pigs has been given as a graph, 
including unspecified isolates. Consideration should be given to show the contribution without 
inclusion of the unspecified isolates.   
2.3.2.2. Data on Campylobacter in food 
Data from poultry, pig and bovine meat as well as from other foodstuffs have been presented.  
Data for fresh broiler poultry meat were presented in a Table with different sections for slaughter, 
processing plants and retail. Sample units were mostly single samples, but in general sample size 
varied between 1g and 25g. For some countries specific explanations were given regarding seasonality 
(e.g. Denmark). Seasonality was not in general included in the analysis, as data were not available on 
that basis. Data for fresh non-broiler poultry meat have been presented in a similar Table, but only a 
few MS reported for this category. 
In the 2009 EU Summary Report the EU-wide baseline survey was presented separately from the 
above mentioned data and comprised prevalence data on broiler carcasses as well as quantitative data 
from broiler carcasses. 
'The data for fresh pig meat and bovine meat were similarly presented as for fresh poultry meat. Only 
data from few MSs were presented in the Tables, as not all MSs did collect such data. Furthermore, 
only the sample size (N) for Germany and the Netherlands (for fresh pig meat) and for Germany (only 
in 2009), Luxembourg (only in 2009) and the Netherlands (for fresh bovine meat) was appropriate to 
calculate percentage positives. 
Meat products from broiler, turkey, pig and bovine meat were summarised in one Table, although only 
data from two to three MSs could be included in the analysis. Almost all products proved to be 
negative, but the sample size for this calculation was very small per country and product. 
Other foodstuffs comprised cows‟ milk, other milk and dairy products. Only five (four in 2010) MSs 
reported for cows‟ milk with a reliable sample size. The data for other milk products were not 
interpretable as the origin of the milk was not specified. Dairy products were in some cases specified 
and comprised mainly cheese. The number of samples was very low. 
The species distribution of Campylobacter in fresh broiler meat has been provided as a graph, 
including unspecified isolates. Consideration should be given to showing the contribution without 
inclusion of the unspecified isolates.   
2.3.3. Conclusion and discussion 
For comparisons, only flock-based data should be considered for poultry. Animal-based data are not 
meaningful, considering the high (up to 100%) intra-herd prevalence of infected poultry flocks. To 
facilitate comparison also for pigs herd-based data should be considered. Only few MSs reported in 
that way. 
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Data from minor species (other farm animals) can be useful in the context of source attribution; 
samples from clinical infected animals cannot be used for this purpose. In other cases, especially when 
only few MSs are reporting, the data could be considered for presentation in an annex. The inclusion 
of pet animal data is relevant but the sampling from non-clinical sources should be encouraged. 
Samples which would allow an estimation of real prevalence would be welcome.  
Concerning the distribution of Campylobacter species in animals and food (poultry) a second graph 
giving the distribution of all isolates properly identified to the species level would be instructive. 
Otherwise the real prevalence of the identified species will be underestimated. The comprehensive 
graph (including unspecified isolates) could be moved to an annex. 
Seasonality should be considered where possible, both for animal sampling and food: in 2009 only 
data from Norway on the sampling season was available. Seasonality can greatly influence the results, 
as is also already stated in the EU Summary Reports. Sample based reporting which allows inclusion 
of seasonality is recommended. 
In general, data from MSs with unspecified sample unit and sample size could be presented in an 
annex. 
The distribution of positive samples throughout the food chain for the different animal species is 
informative. It should be kept in mind that all kind of samples are included (animal, herd and single 
samples) and therefore an interpretation should be made accordingly. Information on sampling 
technique variations etc., would also be helpful. 
General trends over a five-year period have been given for human cases of campylobacteriosis. In the 
2010 EU Summary Report a graph on fresh broiler meat was also provided. Such a trend analysis is 
useful but should be interpreted considering the rationale of data reporting. 
2.4. Listeria  
2.4.1. Listeriosis in humans  
The reported incidence of listeriosis was low compared to other zoonotic and foodborne pathogens, 
but the reported number of fatal cases was the highest of any of the agents in both EU Summary 
Reports. The reported incidence has been presented in a Table and trends over five years were 
visualized for the EU (only for MSs with data from five consecutive years) and for each reporting MS 
in graphs and analysed statistically for trend, which is very informative. There were fluctuations but 
no clear trend in the five-year period. Major differences in reporting MSs, which may affect overall 
trend have been noted. The data collected were case-based, except for two MSs reporting aggregated 
data and one MS not reporting in both years. The presentation of data is appropriate. Those countries 
providing no case-based data could be excluded from the Table and be presented as a footnote. Strong 
deviations of reported cases per 100.000 between MSs are neither noted nor explained - i.e. several 
MSs reporting less than 0.1 cases per 100,000.  
Information on domestic/imported origin of cases has been presented in the text, but was missing for 
approximately 25% of all cases. Where data were available, the majority were from domestic cases. 
Data on seasonality have not been presented. Approximately 60% of cases occur in the elderly (65+) 
while cases in infants accounted for 4 % in 2009 and 6% in 2010 (EFSA, 2011a; 2012a). Complete 
data on age distribution has not been provided. Cases in pregnant women have been indicated under 
„transmission routes‟ but whether such information was complete, or how pregnant women were 
exposed, has not been clearly stated. The basis for assessing the transmission routes for confirmed 
cases and providing this information is unclear and the data are incomplete. The data do not provide a 
basis for the evaluation of the public health impact of food safety programmes. Fatalities have been 
reported, but not foetal deaths or abortions. 
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2.4.2. Data on Listeria in animals and food  
2.4.2.1. Listeria data in animals 
Listeria is common in animals and nature. Several MSs reported data on L. monocytogenes in animals 
especially in cattle, sheep and goats. These data were not especially relevant since the risk of listeriosis 
is linked to contamination (mostly from processing environment) of ready-to-eat foods which support 
the growth of the organism, and not to the prevalence in animals. 
2.4.2.2. Listeria data in food 
Compliance with microbiological criteria 
Data reported reflect the requirements of the Regulation 2073/2005 (European Commission, 2005), 
and investigations have focused on testing RTE foods for compliance with these limits.  
There are some weak points in the assumptions made for the evaluation of the compliance to the 
Regulation 2073/2005. For example it is assumed that products except hard cheeses and fermented 
sausages are able to support growth of the pathogen. Depending on their physicochemical 
characteristics (pH, aw, presence of antimicrobials etc) however, many of these products may not 
support growth of L. monocytogenes. An effective evaluation of the compliance to the safety criteria 
requires the combination of the prevalence and concentration data with data on the physicochemical 
characteristics of the products (mainly pH, water activity (aw)) as well as the remaining shelf life of the 
products after the time of analysis. The need for the above information has been taken into account in 
the L. monocytogenes baseline survey (BS) in certain ready-to-eat foods for 2010/2011 (Commission 
Decision, 2010).
4
 
All data in the report were presented in a qualitative form (i.e. percentage of products with <100 cfu or 
>100 cfu). Such data do not provide a clear picture of the risk of listeriosis. Based on the dose-
response relationship of L. monocytogenes (Figure 2) the risk of listeriosis is mostly related to 
products with high concentrations of the pathogen. For example, assuming a mean serving of 50-100 
grams, the risk of listeriosis for the normal population is significant for products with L. 
monocytogenes concentration higher than 10
3
-10
4
 cfu/g. Thus it is important to analyze the actual 
concentration of the pathogen in RTE products and especially the percentage of products with high 
concentrations.  
Comparison between annual data is affected by the selection of products that are analyzed in relation 
to their ability to support growth of the pathogen. For example, in one year more products that are able 
to support growth are analyzed higher concentration and non-compliance levels are expected. 
The fact that data may not be comparable between MS due to differences in sampling and testing 
schemes should be stressed. 
In all Tables averages have been estimated for the total samples at both processing and retail stages. 
This provides an erroneous picture since the safety criteria are different for the two stages. Averages 
should be estimated for the processing and retail stage separately. In addition it is not clear if these 
                                                     
4
  A Listeria monocytogenes baseline survey (BS) in certain ready-to-eat foods (2010/2011) has been undertaken 
(Commission Decision, 2010). Ready-to-eat food categories chosen were those that have been linked to human listeriosis 
cases and where L. monocytogenes is most often reported according to the results from the “EU summary Reports on trends 
and sources of zoonoses, zoonotic agents and food-borne outbreaks”, also over 100 cfu/g (= legal safety limit), namely: 
Packaged (not frozen) hot or cold smoked or gravad fish, Soft or semi-soft cheeses, excluding fresh cheeses: Packaged 
heat-treated meat products, which have been handled and vacuum or MAP packaged after heat treatment. Testing of all 
three RTE categories will be performed at the end of shelf-life and for smoked/gravad fish: also tested immediately after 
sampling. Details of pH, and aw will be provided and all samples will be analysed with an enumeration method. Thus this 
one-year BS (2010/11) will provide additional valuable information on occurrence of L. monocytogenes in RTE food  
categories which are perceived as being at high risk, growth/no growth characteristics of packaged smoked or gravad fish 
and modelling to estimate the compliance with L. monocytogenes food safety criteria. 
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averages are weighted or not. All figures should be presented separately for the processing and retail 
stage as in the case of Figure LI3 since the safety criteria are different for the two stages.  
2.4.3. Conclusion and discussion 
More data are required for an effective analysis of origin (domestic/imported), seasonality and age 
distribution of listeriosis cases. In general the assessment of the transmission routes for confirmed 
cases is incomplete. The data on listeriosis in humans do not provide any basis for the evaluation of 
the food safety programmes impact (i.e. safety criteria of EU Reg. 2073/2005) on public health. Data 
on the occurrence above or below a certain limit of Listeria in foods have their limitations in relation 
to conclusions on the compliance with the safety criteria, risks, comparison between MSs and in 
relation to trend analyses.  
2.5. VTEC  
2.5.1. Data on VTEC in humans  
Reports of verotoxin-producing Escherichia coli (VTEC) infections are less frequent than those of 
other bacterial zoonoses in the EU but such infections are of particular concern due to their severe 
nature and as causative agents of haemolytic uraemic syndrome (HUS). The reported incidence has 
been presented in a Table and trends over five years have been presented graphically, as well as the 
results of statistical analysis for trend, which is very informative. The reported incidence in the EU has 
increased for four consecutive years, but this fails to reach statistical significance over a 5-year period. 
To what extent this increase is due to better detection and reporting, compared to real trends in disease 
incidence is not clear. Major differences in reporting MSs, that may affect overall trend, have been 
noted. The data collected were case-based, except for three MSs where the reporting system is not 
aggregated; two MSs did not report VTEC. The presentation of data was appropriate. Considerable 
differences in reported cases per 100.000 between MSs were only briefly discussed.  
A separate figure has presented information on seasonality of VTEC infections, separately for O157 
and non-O157 serogroups. Detailed Tables have presented further information on serogroups and 
associated virulence characteristics (more commonly named virulence factors). The importance of 
non-O157 strains is not well known due to differences in surveillance and laboratory methods. 
Harmonisation of isolation of non-O157 strains is needed to better support decisions on the control of 
VTEC at EU level. Further detailed serogroup information has been presented for cases associated 
with HUS. It is confusing that colour codes and the order of specific serogroup was different between 
2009 and 2010. It is not clear how many cases were identified as HUS compared to only diarrhoeal 
cases. Active HUS surveillance is recommended to get better data on the burden of this important 
sequela. 
No information on domestic/imported origin of cases was presented. The data on seasonality were 
presented in a single graph combined with serogroup distribution in 2009, and combined with age 
distribution in 2010. It is not clear why these differences in presentation have been chosen. Whether 
seasonality differs between MSs or geographical regions is not evaluated. Age distribution of cases 
could be discussed more extensively. There was detailed information on serogroup distribution and 
time trends by MSs, which is informative to understand overall trends in more detail. 
In a similar way to the reporting of RDNC and NT in the Salmonella Tables (see earlier), 
consideration should be given to moving the types classified as „Not Typeable (NT)‟ (EFSA, 2012a, 
Table VT3, p.  165), to the bottom of the Table rather than as number two in the „top ten serogroups 
reported each year‟. NT is likely to be a heterogeneous collection of strains, and to give it such 
prominence in the Table is misleading. 
An analysis of the serogroups for the presence of virulence genes has been presented in the 2010 EU 
Summary Report (EFSA, 2012a), which is highly informative. 
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2.5.2. Data on VTEC in animals and food 
2.5.2.1. VTEC data in animals 
Twelve countries reported isolations of VTEC from food animals (cattle and sheep) in 2009 and 
sixteen in 2010 (EFSA, 2011a; 2012a). A wide range of serogroups were identified in those countries 
where serogrouping was undertaken.  
2.5.2.2. VTEC data in food 
Twenty MSs reported data on VTEC in food for 2009 and nineteen MSs and one non-MS for 2010 
(EFSA, 2011a; 2012a). In 2009, 9,285 bovine meat samples were investigated of which 2.3 % were 
VTEC-positive and 0.7 % VTEC O157-positive. In 2010, twelve MSs reported testing of 8,566 bovine 
meat units (from investigations of 25 or more samples) of which 0.5 % were VTEC-positive and 0.1 % 
VTEC O157-positive.  
Comparison between MSs is difficult due to the differences in the methods, sampling schemes and 
reporting system. For example in Table VT4 (EFSA, 2011a) where the VTEC in fresh bovine meat 
was presented for the same description of samples (i.e. fresh) the sample weight included both surface 
and weight sampling (i.e. 400 cm
2
 or 25g). It is not clear if the samples were carcasses, primary cuts or 
final products. In the case of carcasses the sampling stage has not been defined. The sampling stage 
can be important due to the significant effect of certain processing steps (i.e. chilling) on VTEC 
prevalence. 
The reported percentage of samples positive to VTEC O157 for bovine fresh meat at slaughter, 
cutting/processing plant in Spain for 2009 was 14.9% (EFSA, 2011a). In contrast the respective 
prevalence in Spain for the years 2006-2008 was less than 1.3% whilst in 2010 it was 0% (EFSA, 
2012a). This huge deviation needs to be discussed. 
For most MS no information has been provided for other serogroups other than O157.  
The change in prevalence of VTEC in fresh bovine meat during the years 2006-2010 has not been 
presented. Such information is important for trend analysis. For such analysis the differences in 
methods, sampling schemes and reporting systems among MSs should be taken into account. 
2.5.3. Conclusion and discussion 
Comparison between MSs is difficult due to the differences on the methods, sampling schemes and 
reporting system. Methods, sampling schemes and reporting system among MSs should be 
harmonized.  
Analyses should be extended to serogroups other than O157.  
Consideration should be given to moving the types classified as „Not Typeable (NT)‟ (EFSA, 2012a; 
Table VT3, p. 165), to the bottom of the Table rather than as number two in the „top ten serogroups 
reported each year. NT is likely to be a heterogeneous collection of strains, and to give it such 
prominence in the Table is misleading. 
A trend analysis on the change in prevalence of VTEC in fresh bovine meat during the years 2006-
2010, within MSs, could be presented, if data allows. 
An analysis of the serogroups for the presence of virulence genes has been presented in the 2010 EU 
Summary Report (EFSA, 2012a), which is highly informative. 
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2.6. Yersinia  
2.6.1. Yersiniosis in humans  
Yersiniosis in the EU has shown a statistically significant decreasing five-year trend but is still the 
third most frequently reported zoonotic infection. The reported incidence has been presented in a 
Table and trends over five years were presented in the text, as well as the results of statistical analysis 
for trend. Major differences in reporting MSs, that may affect overall trend, have been noted. It would 
be interesting to know if the decrease in trend is seen in all age groups. The data collected were case-
based, except for three MS where the reporting system was not aggregated; two MSs did not report 
Yersinia. The presentation of data is appropriate. Considerable differences in reported cases per 
100.000 were only briefly discussed. Relatively good speciation and travel information data were 
available; about half of the strains were serotyped in 2010 but hardly any were biotyped. Such 
information was not provided in the 2009 report (EFSA, 2012a; 2011a).  
2.6.2. Data on Yersinia in animals and food 
In 2009 and 2010, only six and seven MSs respectively reported data on Yersinia in pig meat and 
products thereof (EFSA, 2011a; 2012a).  
In 2010, four MSs submitted data regarding the testing of animals for Yersinia. The results of the 
reported data for animals in 2008-2010 have been shown. Four MSs provided data regarding Yersinia 
in pigs in 2010, with an overall proportion of Yersinia spp. and Y. enterocolitica-positive units of 12.3 
%. Most of the porcine isolates that tested positive for Y. enterocolitica in 2010 were reported together 
with serotype information (EFSA, 2012a). 
The BIOHAZ Panel concluded in an earlier report (EFSA, 2007) that the best and most reliable 
indicator of Y. enterocolitica pathogenicity is the biotype as the various biotypes are either pathogenic 
or non-pathogenic. The serotype alone is not a reliable marker of Y. enterocolitica pathogenicity 
because several serotypes are common to both pathogenic and non-pathogenic strains.  Most of the 
porcine isolates that tested positive for Y. enterocolitica in 2010 were reported, together with serotype 
information (EFSA, 2012a). 
2.6.3. Conclusion and discussion 
Since only a few MSs report data on Yersinia spp. and Y. enterocolitica and since sample types and 
levels are not specified in most cases the data are not very useful for comparison between countries. In 
the future it is suggested that harmonized data on herd level (number of positive herds) and prevalence 
data for pig carcasses at the end of the slaughterline should be collected. In addition it is recommended 
that all strains are sero- and biotyped (EFSA, 2007). 
2.7. Trichinella  
Trichinella is a well-known parasitic zoonosis, involving twelve species and four genotypes (whereby 
the EU Summary Report mentions only three) (Gottstein et al., 2009). T. spiralis, T. britovi, T. native 
and T. speudospiralis are considered to be the species circulating in Europe. However, T. murelli has 
also been reported from an outbreak in Europe caused by imported horse meat not originating from 
Europe, but so far is not regarded as a species native to Europe. The 2009 report contained an 
extensive section on this zoonotic parasite (EFSA, 2011a).  
2.7.1. Trichinellosis in humans  
There were 748 confirmed cases out of 1073 reported cases in the EU, which is a slight increase to the 
years before. Whether this may also be related to better reporting was not discussed. The highest 
human infection rates were in certain geographical areas. Also the data for some localized outbreaks 
were provided, which is useful in assessing the impact of individual outbreaks. The number of cases 
was found to have markedly decreased in the 2010 EU Summary Report (EFSA, 2012a): with 223 
confirmed cases out of 394 reported cases. 
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The Table also listed the number of imported cases, which is valuable information. If possible the 
probable origin of these cases could be indicated, as this would be helpful. Data were given either on 
case-based reports or aggregated data or sometimes not specified. 
The infections in different age classes have been shown. 
Two countries did not provide information on human cases: Denmark (Trichinella is not a notifiable 
disease in humans) and Greece. Therefore, there were no results on trichinellosis from these two 
countries; information as to whether there are no cases would have been useful. The diagnostic 
methods for Trichinella in humans are not harmonized and not clearly listed for the individual 
countries. 
There were no data on human infection in the French DOMs overseas and some Spanish and 
Portuguese islands in the 2009 EU Summary Report (EFSA, 2011a). No map was shown for 2010 
(EFSA, 2012a). 
2.7.2. Data on Trichinella in animals 
Data on the infection in animals were clearly presented for pigs, farmed wild boar, wild boar and other 
wildlife. The infection was very low in farmed pigs and the infection rate has not noticeably changed 
over the years. Also Trichinella was found in solipeds but this information was only reported in the 
text and not in a Table, even though testing has been systematically done. Information on which type 
of farms the infected pigs came from has not been provided; such information may be helpful with 
regards to the development of risk-based surveillance in farmed pigs.  
A harmonized monitoring scheme was also proposed by the EFSA scientific report: “Development of 
harmonised schemes for the monitoring and reporting of Trichinella in animals and foodstuffs in the 
European Union, EFSA January 2012” with useful suggestion for the harmonization of testing.  
Especially in the Eastern EU regions wild life is heavily infected, and racoon dog appear to be an 
important reservoir. No testing is done on a regular level. 
A risk-based assessment is currently undertaken in the frame of Scientific Opinions related to meat 
inspection by EFSA (EFSA, 2011d; EFSA, 2011e).   
2.7.3. Overview of Trichinella from farm-to-fork 
There was a positive correlation between the number of positive pigs and wild boar and the number of 
human cases, indicating that there is a relationship between consumption of pork and infection. 
2.7.4. Conclusion and discussion 
The 2009 report contained an extensive section on Trichinella, which was overall well presented. A 
large collection of data was presented but there is still no completely harmonized monitoring scheme 
for this organism. Data on different Trichinella species and genotypes are often lacking. More 
information on the origin in the human and animal cases would be useful for control purposes.  
Whilst the number of human infections increased in 2009 in comparison with the numbers in the 
previous report, they decreased in the 2010; possible reasons for this decline were not discussed.  
Reservoirs of Trichinella are in the wild animals such as wild boar, foxes and racoon dogs, which are 
currently not tested on a regular basis in all MSs. If the aim is to have a continuous surveillance as 
indicator to the risk then wild life should be in focus. Missing data from individual MSs should be 
collected. 
The presentation in the maps could be improved by either a different colour code or even better be 
differently patterned. The maps are difficult to read, especially when printed out in black and white. It 
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would be helpful to have a different annotation system to clearly refer to the Tables in the annex, as 
well as within the text.  
2.8. Toxoplasma  
Toxoplasma is commonly found in a wide number of animal species as well as humans and has a 
global distribution. Seropositive rates differ among European countries (Papas et al. 2009).  
Toxoplasma infections in pregnant women may lead to abortions, stillbirth or congenital disease 
(hydrocephalus, intra-cranial calcifications, chorioretinitis). Toxoplasmosis acquired later in life is 
asymptomatic or causing mild illness in most cases, but is increasingly also recognized as an important 
agent of ocular disease. Because consequences of toxoplasmosis are life-long the disease burden is 
high; for example, in the Netherlands Toxoplasma was ranked first among 14 enteric pathogens, using 
DALYs as risk metric (Havelaar et al, 2012b). In addition, Toxoplasma was ranked as a medium risk 
in the meat inspection opinion on swine (EFSA, 2011d). 
2.8.1. Toxoplasmosis in humans  
The data on humans were difficult to interpret, since some countries monitor toxoplasmosis whereas 
others do not. It is not clear from the Table To2 in the 2009 report whether only congenital cases have 
been reported or which other cases are included (EFSA, 2011a). In the 2010 report (EFSA, 2012a) 
only congenital toxoplasmosis was supposed to be reported due to a change of the case definition 
(Commission Decision, 2008). Not only congenital cases but also ocular toxoplasmosis can also be a 
problem. Only disease in children was reported, even though consequences in the infected babies can 
develop later in life. 
Data on seropositivity were not reported. Screening in pregnant women is undertaken, in some 
countries on a regular basis, and in others voluntarily. These data should be presented.  
Information on source attribution is needed to focus management activities. 
In some countries, where congenital toxoplasmosis is notifiable (EFSA, 2011a; p.375), the data do not 
appear in the Table on human cases. Because of the high burden in MS, a more systematic 
surveillance of clinical and subclinical cases is needed. 
2.8.2. Data on Toxoplasma in animals 
Data from the animals were presented. It was clear from 18 MSs who reported data that infections 
were ubiquitous.  
Regrettably comparisons between countries are difficult. It may not be possible to compare between 
countries due to possible different diagnostic techniques, which are not always clearly stated. Serology 
in cattle is not a valid source of information as it does not correlate with infection or viable oocysts. 
More specific information is needed for the attribution of the source of the parasite. Information on 
viable tissue cysts as well as information on infection in cats as shedders of the oocysts in the 
environment would be needed to identify the food which represents a risk factor as possible 
transmitter of the parasite. 
Findings of Toxoplasma in sheep and goats, where the level is almost 25%, should be given greater 
prominence (see Table 3.11.2. Table TO3 (EFSA, 2011a, section 3.11.2). In other animals the 
prevalence was relatively low with the exception of cats where it was higher. Because of their 
structure the Tables reporting the Toxoplasma infection in animals were not very easy to read, since 
animal types were included in lines and were difficult to find. Perhaps a more elegant solution could 
be found.  The high incidence of toxoplasma in sheep and goats should be highlighted in discussions.  
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2.8.3. Conclusion and discussion 
Data from humans and animals needs to be harmonized by using standardised sampling and diagnostic 
techniques. For humans, this includes data on incidence and disease burden. The case definition has to 
be very clear and the different types of toxoplasmosis infection and disease clearly differentiated. 
Congenital cases should perhaps be presented separately from seropositive data and cases of ocular 
toxoplasmosis. More information is needed related to the source attribution of the infection. This is 
important for management options. 
2.9. Food-borne outbreaks 
The reporting of investigated food-borne outbreaks has been mandatory for EU MSs since 2005. 
Starting from 2007, harmonised specifications on the reporting of these outbreaks at EU level have 
been applied. The food-borne outbreak investigations and reporting systems at national level are not 
harmonized within EU MSs. Differences in the numbers and types of reported outbreaks, as well as 
causative agents, may therefore not necessarily reflect levels of food safety between MSs, but may 
rather be indicative of the differences in the efficiency and sensitivity of the national systems for 
identifying and investigating food-borne outbreaks. Data from 2009 and 2010 provided information on 
the total number of reported food-borne outbreaks attributed to different causative agents, including 
food-borne outbreaks in which the causative agent was unknown (EFSA, 2011a; 2012a). 
The 2009 specifications for food-borne outbreak reporting defined the strength of evidence that could 
link cases to a food vehicle drawing a distinction between “verified” and “possible” food-borne 
outbreaks. Detailed data were only reported for verified food-borne outbreaks, defined as those in 
which the causative agent had been detected in the food vehicle or where the food vehicle had been 
identified by analytical epidemiology. This approach has some limitations, including lack of 
acknowledgement that the nature of evidence is not necessarily correlated with its strength. Another 
difficulty is the reluctance, for legal reasons, of some MSs to identify a particular food vehicle as 
“verified”. Because of these limitations, EFSA has revised the food-borne outbreak reporting 
specifications (EFSA, 2010d). Thus in 2010 (EFSA, 2012a), the distinction between „verified‟ and 
„possible‟ food-borne outbreaks was abandoned in the reporting; instead, outbreaks were categorised 
as „strong evidence‟ or „weak evidence‟ outbreaks based on the strength of evidence implicating a 
suspect food vehicle. In the former case, i.e. where the evidence implicating a particular food vehicle 
was strong, based on an assessment of all available evidences, a detailed dataset was reported for food-
borne outbreaks. In the latter case, i.e. where no particular food vehicle was suspected or for 
foodborne outbreaks where the evidence implicating a particular food vehicle was weak, only a 
limited dataset was reported. This included the number of outbreaks per causative agent and the 
number of human cases hospitalisations and deaths. In the report the term „weak evidence outbreak‟ 
also covered the outbreaks for which no particular food vehicle was suspected. 
2.9.1. Conclusion and discussion 
Taking into account the weakness of the non-harmonised outbreak investigation and reporting system 
at the national level and thereby the different level of details in the reported data, the data were in 
general dealt with in a sufficient and comprehensive way in the 2009 and 2010 EU Summary Reports 
(EFSA, 2011a; 2012a). 
The usefulness of attributing outbreaks, where toxin-producing bacteria like Bacillus, Staphylococcus 
and Clostridium are the causative agents, to specific categories of raw foods could be discussed. 
Species need to be defined when presented in the report. Outbreaks involving these toxin-producing 
bacteria are mostly caused by inappropriate procedures during processing and storage and not or to a 
lower degree to the presence in a particular raw food like meat, egg and milk. Therefore at least as an 
addition it could be informative to attribute outbreaks from these specific organisms to the settings 
where these infections are acquired. Also, it would be interesting to gain knowledge about to what 
extent outbreaks (from all organisms) are caused by industrial processed foods compared to food 
handled and prepared at restaurants, in households and similar settings.  
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For Salmonella, where much data are available, it could be relevant to see whether there was a 
correlation between the number of countries with high prevalence of Salmonella in eggs, poultry and 
other meat and the number of outbreaks caused by these sources. This could be done by using the 
source attribution approach based on outbreak data, as described by Pires et al. (2010). 
Another suggestion for improvement of future reports would be to link the discussion on the specific 
food-borne outbreaks (Salmonella, Campylobacter, VTEC, viruses, parasites etc.) to the general data 
and chapters where the general data on these pathogens are discussed. 
 
GENERAL CONCLUSIONS AND RECOMMENDATIONS 
Comparison between EU Member States (MSs) is difficult due to the differences of the methods used, 
sampling schemes and reporting systems. Methods, sampling schemes and reporting systems among 
MSs should be harmonized.  
Data on human cases were reported via The European Surveillance System (TESSy) to ECDC by the 
27 MSs and three EEA/EFTA countries (Iceland, Lichtenstein and Norway). Switzerland reported 
human cases directly to EFSA. The completeness of reporting varied between both MSs and 
pathogens. 
The data reported to ECDC did not provide for an accurate picture of the epidemiological situation in 
the EU as they did not account for underreporting and under-ascertainment. The ratio between true 
cases and reported cases is known to vary widely between MSs and between pathogens, making 
comparisons extremely difficult. These limitations also affect the accuracy of risk assessment and 
attribution studies and furthermore may lead to inappropriate estimates of the cost-benefit ratio of 
interventions.  
Incidence data alone do not provide a full picture of the public health burden of zoonotic diseases. 
Fatalities provide another important insight. Ultimately, summary measures of public health such as 
disability adjusted life years (DALYs) and cost-of-illness estimates should be presented.  
Trends in reported cases are assumed to provide insight in the changes in disease incidence, and thus 
for the evaluation of control programs. Supporting evidence for the assumption that the sensitivity of 
surveillance systems does not change over the years has not been provided. Evaluation of the public 
health impact of food safety programmes is further hampered by a lack of risk factor information. 
Travel information is still incomplete in many MSs. For many pathogens this hampers source 
attribution. To better understand the public health problems related to food and animal sources in the 
EU, it is desirable to differentiate between travel within and outside the EU. This would also be useful 
to better evaluate the public health impact of EU-wide food safety measures. 
Whenever possible the data/results should be analysed using proper statistical tools. When data do not 
allow for this, the text should be kept to presenting the data without implying any patterns or trends. 
This also relates to use of words or phrases like “only” and “very low” contamination in e.g. RTE 
turkey and bovine meat, respectively. Such words imply an acceptance of the contamination level, 
which is outside the scope of the report. Phrases like “lower or higher than” are only considered 
appropriate to use when comparing trends from e.g. year to year, if supported by proper statistical 
analyses. 
When comparing MS-specific trends, the impact of sample sizes, weight of samples and 
methodologies should be considered, as these could otherwise lead to misinterpretation of the data. In 
addition data from MSs, where sample unit and sample size were unspecified could be presented in an 
annex. 
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